Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Author(s) -
Robert K. Heaton,
Donald Franklin,
R Deutsch,
Scott Letendre,
Ronald J. Ellis,
Kaitlin B. Casaletto,
María J. Marquine,
Steven Paul Woods,
Florin Vaida,
J. Hampton Atkinson,
Thomas D. Marcotte,
J. Allen McCutchan,
Ann C. Collier,
Christina M. Marra,
David B. Clifford,
Benjamin B. Gelman,
Ned Sacktor,
Susan Morgello,
David M. Simpson,
Ian Abramson,
Anthony Gamst,
Christine FennemaNotestine,
Davey M. Smith,
Igor Grant,
Thomas S. Alexander,
Edmund V. Capparelli,
Mark A. Dawson,
Michael J. Taylor,
Rebecca J. Theilmann,
Clint Cushman,
J. Marquie-Beck,
J. McArthur,
V. Rogalski,
Letty Mintz,
Will Toperoff,
Timothy A. Jones,
Eleanor Head,
M. Al-Lozi,
Mahlet Belachew
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu862
Subject(s) - medicine , neurocognitive , antiretroviral therapy , charter , human immunodeficiency virus (hiv) , virology , psychiatry , viral load , cognition , archaeology , history
Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) can show variable clinical trajectories. Previous longitudinal studies of HAND typically have been brief, did not use adequate normative standards, or were conducted in the context of a clinical trial, thereby limiting our understanding of incident neurocognitive (NC) decline and recovery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom